Filter by patients with: All

What is SB-509?

Category: Others

false

The purpose of the study is to evaluate the effects of the drug, SB-509 on progression of the disease in subjects with Amyotrophic Lateral Sclerosis (ALS).

See patients taking SB-509

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Participate in clinical trial 1 3
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 5 patients that have used SB-509

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 3

Commonly reported side effects and conditions associated with SB-509

Side effect Patients Percentage

Why patients stopped taking SB-509

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 1
See 1 patient who's stopped using SB-509

Duration

Stopped using SB-509

Duration Patients Percentage
1 - 6 months 1
Adherence
Adherence Evaluations Percentage
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 2
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 2
Last updated:

1 patient evaluation for SB-509

Sort by: Most recent

Dec 1, 2009 (Started Aug 04, 2009)

  • Effectiveness
    None (for Participate in clinical trial)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 56 other One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

Oct 31, 2009 (Started Aug 04, 2009)

  • Effectiveness
    None (for Participate in clinical trial)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 56 other One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Oct 15, 2009 (Started Aug 04, 2009)

  • Effectiveness
    Can't tell (for Participate in clinical trial)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 56 other One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for SB-509